Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 4 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.


Player Avatar chris293 (86.22) Submitted: 2/27/2013 10:13:18 PM : Outperform Start Price: $46.89 VRTX Score: +112.25

Vertex is on the leading edge for new cures of many dieases and inflections. Maybe the year of stocks ending with an 'x' is back. Micro-cures could be the answers to what ails us.

Featured Broker Partners